Completing data — refresh the page later to see the latest
41332-24-5O=C(CC(c1ccccc1)c1ccccc1)N1CCN(C(c2ccccc2)c2ccccc2)CC1VCPMZDWBEWTGNW-UHFFFAOYSA-NZ160 has been used in trials studying the treatment of Postherpetic Neuralgia and Lumbosacral Radiculopathy.
41332-24-5Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
UsesAn analog of Cinnarizine (C465300), a calcium channel blocker as anti-inflammatory agent.
DTXSID70407284CHEMBL604710